Denali Therapeutics Inc.
DNLI
Revenue
0.00
0.000.00%
3 Months ChangeAssets
1.50B
▼-78.53M▼-4.97%
3 Months ChangeLiabilities
115.51M
▼-10.10M▼-8.04%
3 Months ChangeFree Cash Flow
-115.77M
▼-54.18M▼-87.97%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-10
Form 8-K
ID: 0001714899-24-000205
2024-08-01
Form 10-Q
ID: 0001714899-24-000169
2024-08-01
Form 8-K
ID: 0001714899-24-000168
2024-05-31
Form 8-K
ID: 0001714899-24-000125
2024-05-07
Form 10-Q
ID: 0001714899-24-000121
2024-05-07
Form 8-K
ID: 0001714899-24-000120
2024-02-27
Form 8-K
ID: 0001714899-24-000076
2024-02-27
Form 8-K
ID: 0001714899-24-000075
2024-02-16
Form 8-K
ID: 0001714899-24-000065
2024-01-08
Form 8-K
ID: 0001714899-24-000031